Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family

Biochemistry

Volumn 42, Issue 3, 2003, Pages 694-701

  Ajami, Katerina ^a   Abbott, Catherine A ^a,b   Obradovic, Mina ^a   Gysbers, Vanessa ^a   Kähne, Thilo ^c   McCaughan, Geoffrey W ^a   Gorrell, Mark D ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL COSTIMULATION;

BIOSYNTHESIS; CELLS; DISEASES; GENES; PROTEINS;

BIOCHEMISTRY;

ASPARTIC ACID; CHEMOKINE; CHIMERIC PROTEIN; DIPEPTIDYL PEPTIDASE IV; GLUTAMIC ACID; HISTIDINE; HYDROLASE; NEUROPEPTIDE Y; PROLYL ENDOPEPTIDASE; SERINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CONTROLLED STUDY; DELETION MUTANT; DIMERIZATION; ENZYME ACTIVITY; ENZYME STRUCTURE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIGENE FAMILY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD26; CATALYSIS; CATALYTIC DOMAIN; CELL LINE; CONSERVED SEQUENCE; COS CELLS; DIMERIZATION; GENE EXPRESSION REGULATION; HUMANS; HYDROLASES; MULTIGENE FAMILY; MUTAGENESIS, SITE-DIRECTED; POINT MUTATION; RATS; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION; SEQUENCE HOMOLOGY, AMINO ACID; SERINE ENDOPEPTIDASES; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

ANIMALIA;

EID: 0347367026     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi026846s     Document Type: Article

References (42)

1. Mentlein, R. (1999) Dipeptidyl-peptidase IV (CD26): role in the inactivation of regulatory peptides, Regul. Pept. 85, 9-24.
2. De Meester, I., Durinx, C., Bal, G., Proost, P., Struyf, S., Goossens, F., Augustyns, K., and Scharpé, S. (2000) Natural substrates of dipeptidyl peptidase IV, Adv. Exp. Med. Biol. 477, 67-88.
3. Gorrell, M. D., Gysbers, V., and McCaughan, G. W. (2001) CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes, Scand. J. Immunol. 54, 249-264.
4. Deacon, C. F., and Holst, J. J. (2002) Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective, Biochem. Biophys. Res. Commun. 294, 1-4.
5. Langner, J., and Ansorge, S. (2002) Ectopeptidases: CD3/Aminopeptidase N and CD26/Dipeptidylpeptidase IV in Medicine and Biology, Vol. ISBN 0-306-46788-7, Kluwer/Plenum, New York.
6. Ohtsuki, T., Tsuda, H., and Morimoto, C. (2000) Good or evil: CD26 and HIV infection, J. Dermatological Sci. 22, 152-160.
7. McCaughan, G. W., Gorrell, M. D., Bishop, G. A., Abbott, C. A., Shackel, N. A., McGuinness, P. H., Levy, M. T., Sharland, A. F., Bowen, D. G., Yu, D., Slaitini, L., Church, W. B., and Napoli, J. (2000) Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance, Immunol. Rev. 174, 172-191.
8. Herrera, C., Morimoto, C., Blanco, J., Mallol, J., Arenzana, F., Lluis, C., and Franco, R. (2001) Comodulation of CXCR4 and CD26 in human lymphocytes, J. Biol. Chem. 276, 19532-19539.
9. Shioda, T., Kato, H., Ohnishi, Y., Tashiro, K., Ikegawa, M., Nakayama, E. E., Hu, H., Kato, A., Sakai, Y., Liu, H., Honjo, T., Nomoto, A., Iwamoto, A., Morimoto, C., and Nagai, Y. (1998) Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage, Proc. Natl. Acad. Sci. U.S.A. 95, 6331-6336.
10. Lambeir, A. M., Proost, P., Durinx, C., Bal, G., Senten, K., Augustyns, K., Scharpe, S., Van Damme, J., and De Meester, I. (2001) Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family, J. Biol. Chem. 276, 29839-29845.
11. Drucker, D. J. (2002) Biological actions and therapeutic potential of the glucagon-like peptides, Gastroenterology 122, 531-544.
12. Ahren, B., Simonsson, E., Larsson, H., Landin-Olsson, M., Torgeirsson, H., Jansson, P. A., Sandqvist, M., Bavenholm, P., Efendic, S., Eriksson, J. W., Dickinson, S., and Holmes, D. (2002) Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes, Diabetes Care 25, 869-875.
13. Abbott, C. A., McCaughan, G. W., Levy, M. T., Church, W. B., and Gorrell, M. D. (1999) Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain, Eur. J. Biochem. 266, 798-810.
14. Barrett, A. J., Rawlings, N. D., and O'Brien, E. A. (2001) The MEROPS database as a protease information system, J. Struct. Biol. 134, 95-102.
15. Abbott, C. A., and Gorrell, M. D. (2002) The family of CD26/DPIV and related ectopeptidases, in Ectopeptidases: CD3/Aminopeptidase N and CD26/Dipeptidylpeptidase IV in Medicine and Biology (Langner, J., and Ansorge, S., Eds.) pp 171-195, Kluwer/Plenum, New York.
16. Fülop, V., Bocskei, Z., and Polgar, L. (1998) Prolyl oligopeptidase an unusual beta-propeller domain regulates proteolysis, Cell 94, 161-170.
17. Fülop, V., Szeltner, Z., and Polgar, L. (2000) Catalysis of serine oligopeptidases is controlled by a gating filter mechanism, EMBO Rep. 1, 277-281.
18. Abbott, C. A., McCaughan, G. W., and Gorrell, M. D. (1999) Two highly conserved glutamic acid residues in the predicted beta propeller domain of dipeptidyl peptidase IV are required for its enzyme activity, FEBS Lett. 458. 278-284.
19. David, F., Bernard, A. M., Pierres, M., and Marguet, D. (1993) Identification of serine 624, aspartic acid 702, and histidine 734 as the catalytic triad residues of mouse dipeptidyl-peptidase IV (CD26). A member of a novel family of nonclassical serine hydrolases, J. Biol. Chem. 268, 17247-17252.
20. Fan, H., Meng, W., Kilian, C., Grams, S., and Reutter, W. (1997) Domain-specific N-glycosylation of the membrane glycoprotein dipeptidylpeptidase IV (CD26) influences its subcellular trafficking, biological stability, enzyme activity and protein folding, Eur. J. Biochem. 246, 243-251.
21. Hühn, J., Olek, S., Fleischer. B., and von Bonin, A. (1999) The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule, Cell. Immunol. 192, 33-40.
22. Dong, R. P., Tachibana, K., Hegen, M., Munakata, Y., Cho, D., Schlossman, S. F., and Morimoto, C. (1997) Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation, J. Immunol. 159, 6070-6076.
23. Levy, M. T., McCaughan, G. W., Abbott, C. A., Park, J. E., Mueller, E., Cunningham, A. M., Rettig, W. J., and Gorrell, M. D. (1999) Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis, Hepatology 29, 1768-1778.
24. Park, J. E., Lenter, M. C., Zimmermann, R. N., Garin-Chesa, P., Old, L. J., and Rettig, W. J. (1999) Fibroblast activation protein: A dual-specificity serine protease expressed in reactive human tumor stromal fibroblasts, J. Biol. Chem. 274, 36505-36512.
25. Abbott, C. A., Yu, D. M. T., Woollatt, E., Sutherland, G. R., McCaughan, G. W., and Gorrell, M. D. (2000) Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8, Eur. J. Biochem. 267, 6140-6150.
26. Ajami, K., Abbott, C. A., McCaughan, G. W., and Gorrell, M. D. (2002) Human dipeptidyl peptidase (DP) 9: A novel DPIV/CD26 homolog, manuscript in preparation.
27. Ogata, S., Misumi, Y., and Ikehara, Y. (1989) Primary structure of rat liver dipeptidyl peptidase IV deduced from its cDNA and identification of the NH2-terminal signal sequence as the membrane-anchoring domain, J. Biol. Chem. 264, 3596-3601.
28. Oravecz, T., Pall, M., Roderiquez, G., Gorrell, M. D., Ditto, M., Nguyen, N. Y., Boykins, R., Unsworth, E., and Norcross, M. A. (1997) Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation normal T cell expressed and activated) by dipeptidyl peptidase IV (CD26)-mediated cleavage, J. Exp. Med. 186, 1865-1872.
29. Durinx, C., Lambeir, A. M., Bosmans, E., Falmagne, J. B., Berghmans, R., Haemers, A., Scharpe, S., and De Meester, I. (2000) Molecular characterization of dipeptidyl peptidase activity in serum - Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides, Eur. J. Biochem. 267, 5608-5613.
30. Kähne, T., Kroning, H., Thiel, U., Ulmer, A. J., Flad, H. D., and Ansorge, S. (1996) Alterations in structure and cellular localization of molecular forms of DP IV/CD26 during T cell activation, Cell. Immunol. 170, 63-70.
31. De Meester, I., Vanham, G., Kestens, L., Vanhoof, G., Bosmans, E., Gigase, P., and Scharpé, S. (1994) Binding of adenosine deaminase to the lymphocyte surface via CD26, Eur. J. Immunol. 24, 566-570.
32. Gorrell, M. D., Levy, M. T., Abbott, C. A., Washington, E. A., and McCaughan, G. W. (1997) CD26: Adenosine deaminase binding, immunoblotting, and species cross reactivity examined using recombinant proteins, in Leucocyte Typing VI (Kishimoto, T., Ed.) pp 484-485, Garland Publishing Inc., New York.
33. Tanaka, T., Camerini, D., Seed, B., Torimoto, Y., Dang, N. H., Kameoka, J., Dahlberg, H. N., Schlossman, S. F., and Morimoto, C. (1992) Cloning and functional expression of the T cell activation antigen CD26, J. Immunol. 149, 481-486.
34. Abbott, C. A., Gorrell, M. D., Levy, M. T., and McCaughan, G. W. (1997) Molecular analyses of human and rat dipeptidyl peptidase IV, Adv. Exp. Med. Biol. 421, 161-170.
35. Ohnuma, K., Munakata, Y., Ishii, T., Iwata, S., Kobayashi, S., Hosono, O., Kawasaki, H., Dang, N. H., and Morimoto, C. (2001) Soluble CD26/dipeptidyl peptidase IV induces T cell proliferation through CD86 up-regulation on APCs, J. Immunol. 167, 6745-6755.
36. Fülop, V., and Jones, D. T. (1999) Beta propellers: structural rigidity and functional diversity, Curr. Opinion Struct. Biol. 9, 715-721.
37. McCaughan, G. W., Wickson, J. E., Creswick, P. F., and Gorrell, M. D. (1990) Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N-terminal amino acid sequence, Hepatology 11, 534-544.
38. Gorrell, M. D., Wickson, J., and McCaughan, G. W. (1991) Expression of the rat CD26 antigen (dipeptidyl peptidase IV) on subpopulations of rat lymphocytes, Cell. Immunol. 134, 205-215.
39. Bednarczyk, J. L., Carroll, S. M., Marin, C., and McIntyre, B. W. (1991) Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation, J. Cell. Biochem. 46, 206-218.
40. De Meester, I., Vanhoof, G., Hendriks, D., Demuth, H. U., Yaron, A., and Scharpé, S. (1992) Characterization of dipeptidyl peptidase IV (CD26) from human lymphocytes, Clin. Chim. Acta 210, 23-34.
41. Villhauer, E. B., Brinkman, J. A., Naderi, G. B., Dunning, B. E., Mangold, B. L., Mone, M. D., Russell, M. E., Weldon, S. C., and Hughes, T. E. (2002) new DPP-IV inhibitor class, J. Med. Chem. 45, 2362-2365.
42. Yasuda, N., Nagakura, T., Yamazaki, K., Inoue, T., and Tanaka, I. (2002) Improvement of high fat-diet-induced insulin resistance in dipeptidyl peptidase IV-deficient Fischer rats, Life Sci. 71, 227-238.